Neurodegenerative diseases are among the leading causes of mortality and disability worldwide. However, current therapeutic approaches have failed to reach significant results in their prevention and cure. Protein Kinase Cs (PKCs) are kinases involved in the pathophysiology of neurodegenerative diseases, such as Alzheimer's Disease (AD) and cerebral ischemia. Specifically epsilon, delta, and gamma PKC are associated with the endogenous mechanism of protection referred to as ischemic preconditioning (IPC). Existing modulators of PKCs, in particular of epsilon PKC, such as psi epsilon Receptor for Activated C-Kinase (psi epsilon RACK) and Resveratrol, have been proposed as a potential therapeutic strategy for cerebrovascular and cognitive diseases. PKCs change in expression during aging, which likely suggests their association with IPC-induced reduction against ischemia and increase of neuronal loss occurring in senescent brain. This review describes the link between PKCs and cerebrovascular and cognitive disorders, and proposes PKCs modulators as innovative candidates for their treatment. We report original data showing epsilon PKC reduction in levels and activity in the hippocampus of old compared to young rats and a reduction in the levels of delta PKC and gamma PKC in old hippocampus, without a change in their activity. These data, integrated with other findings discussed in this review, demonstrate that PKCs modulators may have potential to restore age-related reduction of endogenous mechanisms of protection against neurodegeneration.

Pastore, D., Pacifici, F., Dave, K.r., Palmirotta, R., Bellia, A., Pasquantonio, G., et al. (2019). Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(14), 3544 [10.3390/ijms20143544].

Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection

Pastore D.;Pacifici F.;Bellia A.;Pasquantonio G.;Donadel G.;Di Daniele N.;Lauro D.;Della-Morte D.
2019-01-01

Abstract

Neurodegenerative diseases are among the leading causes of mortality and disability worldwide. However, current therapeutic approaches have failed to reach significant results in their prevention and cure. Protein Kinase Cs (PKCs) are kinases involved in the pathophysiology of neurodegenerative diseases, such as Alzheimer's Disease (AD) and cerebral ischemia. Specifically epsilon, delta, and gamma PKC are associated with the endogenous mechanism of protection referred to as ischemic preconditioning (IPC). Existing modulators of PKCs, in particular of epsilon PKC, such as psi epsilon Receptor for Activated C-Kinase (psi epsilon RACK) and Resveratrol, have been proposed as a potential therapeutic strategy for cerebrovascular and cognitive diseases. PKCs change in expression during aging, which likely suggests their association with IPC-induced reduction against ischemia and increase of neuronal loss occurring in senescent brain. This review describes the link between PKCs and cerebrovascular and cognitive disorders, and proposes PKCs modulators as innovative candidates for their treatment. We report original data showing epsilon PKC reduction in levels and activity in the hippocampus of old compared to young rats and a reduction in the levels of delta PKC and gamma PKC in old hippocampus, without a change in their activity. These data, integrated with other findings discussed in this review, demonstrate that PKCs modulators may have potential to restore age-related reduction of endogenous mechanisms of protection against neurodegeneration.
Pubblicato
Rilevanza internazionale
Editoriale
Esperti anonimi
Settore MED/09 - Medicina Interna
Settore MED/13 - Endocrinologia
Settore MED/04 - Patologia Generale
English
Alzheimer’s Diseases; aging; brain; cerebrovascular disease; ischemic preconditioning; modulators; neurodegenerative diseases; pharmacogenetics; protein kinase c
Pastore, D., Pacifici, F., Dave, K.r., Palmirotta, R., Bellia, A., Pasquantonio, G., et al. (2019). Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(14), 3544 [10.3390/ijms20143544].
Pastore, D; Pacifici, F; Dave, Kr; Palmirotta, R; Bellia, A; Pasquantonio, G; Guadagni, F; Donadel, G; Di Daniele, N; Abete, P; Lauro, D; Rundek, T; Perez-Pinzon, Ma; Della-Morte, D
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Age dependent level of protein..-ijms-20-03544.pdf

accesso aperto

Descrizione: articolo principale
Licenza: Copyright dell'editore
Dimensione 1.26 MB
Formato Adobe PDF
1.26 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/224479
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 6
social impact